Recommendations for the management of MDS
The European LeukemiaNet WP8 has promoted a program aiming at developing and continuously updating evidence- and consensus-based guidelines to provide clinical practice recommendations for standardized diagnostic and prognostic procedures and for an appropriate choice of therapeutic interventions in adult patients with primary MDS.
Pocket card
MDS Pocket card 2014
(76KB)Diagnosis and treatment of primary myelodysplastic syndromes (MDS) in adults. Recommendations from the European LeukemiaNet
Order form
(77KB)for MDS pocket card 2014
Malcovati L et al., Blood. 2013;122(17):2943-64.
Westers TM et al., Leukemia. 2012;26(7):1730-41.
Della Porta MG et al., Haematologica. 2012;97(8):1209-17.
van de Loosdrecht AA et al., Haematologica. 2009;94(8):1124-34.
van de Loosdrecht AA et al., Haematologica. 2009 Aug;94(8):1124-34.
Vardiman JW et al., Blood. 2009 Jul 30;114(5):937-51.
Valent P et al., Ann Hematol. 2009 Jul;88(7):607-11.
de Witte T et al., Haematologica. 2006 Jun;91(6):750-6.
MDS_guidelines_methods_2006.pdf
Diagnostic and prognostic procedures adult MDS WP8 090219.pdf
To be used and completed by physicians for their own purposes
Guidelines RNA and DNA isolation from peripheral blood and bone marrow cells and cDNA synthesis